Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tuvemo

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Acta Paediatrica (Oslo, Norway : 1992)|January 1, 1995
Thyroid autoantibodies, Turner's syndrome and growth hormone therapyS A Ivarsson, U B Ericsson, K O Nilsson, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 30, 2004
Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early pubertyT Tuvemo, B Jonsson, J Gustafsson, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 2, 1999
Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimensK Albertsson Wikland, F Alm, S Aronsson, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 16, 1999
Prevalence of coeliac disease in Turner syndromeS A Ivarsson, A Carlsson, A Bredberg, et al.
Diabetologia|March 1, 1997
Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre studyA Kernell, I Dedorsson, B Johansson, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1996
Improved final height in girls with Turner's syndrome treated with growth hormone and oxandroloneK O Nilsson, K Albertsson-Wikland, J Alm, et al.
Genes and Immunity|July 21, 2007
IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5J-H Shin, M Janer, B McNeney, et al.
Genes and Immunity|June 8, 2007
SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patientsS K Sedimbi, X R Luo, C B Sanjeevi, et al.
Acta Diabetologica|September 5, 2008
Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered riskSabina Resic-Lindehammer, K Larsson, E Ortqvist, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Acta Paediatrica (Oslo, Norway : 1992)|January 1, 1995
Thyroid autoantibodies, Turner's syndrome and growth hormone therapyS A Ivarsson, U B Ericsson, K O Nilsson, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 30, 2004
Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early pubertyT Tuvemo, B Jonsson, J Gustafsson, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 2, 1999
Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimensK Albertsson Wikland, F Alm, S Aronsson, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 16, 1999
Prevalence of coeliac disease in Turner syndromeS A Ivarsson, A Carlsson, A Bredberg, et al.
Diabetologia|March 1, 1997
Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre studyA Kernell, I Dedorsson, B Johansson, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1996
Improved final height in girls with Turner's syndrome treated with growth hormone and oxandroloneK O Nilsson, K Albertsson-Wikland, J Alm, et al.
Genes and Immunity|July 21, 2007
IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5J-H Shin, M Janer, B McNeney, et al.
Genes and Immunity|June 8, 2007
SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patientsS K Sedimbi, X R Luo, C B Sanjeevi, et al.
Acta Diabetologica|September 5, 2008
Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered riskSabina Resic-Lindehammer, K Larsson, E Ortqvist, et al.
Pageof 15